To continue getting breaking news and the full stories from The Boston Globe, subscribe today.

The Boston Globe

Metro

Little scrutiny as drug compounder expanded

Early fears about tainted products, but no crackdown

In February 2003, 11 federal and state health regulators gathered around a conference table in Boston, joined by three colleagues patched in on telemonitors from Washington, to decide the fate of New England Compounding ­Center.

The tiny Massachusetts pharmacy seemed too obscure to require so much firepower. But at least four patients had recently died of meningitis caused by contaminated steroid injections made by compounding pharmacies in California and South Carolina, and federal investigators were worried they could have another public health crisis on their hands, according to documents provided by a US Senate committee and the US Food and Drug ­Administration.

Comments

This is a great piece of investigative reporting. I would love to see what relationship our politicians, especially Scott "Mr. Clean" Scott Brown had with the owners of New England Compounding as they flew under the radar of professionalism and ethics. The Mass department of health should be held accountable, as well. Maybe Governor Patrick needs to focus more on matters back home? Oh wait, Vice Governor Murray probably took care of health care regulations. Enough said.

Replies

The state officials that looked the other way should be held as accountable as this company. What a disgrace on so many levels!

This comment has been removed.

Which Deval/timmy Murray contributor was in charge of overseeing this mess?

Replies

It should be noted that the initial problem with this pharmacy was in 2003. Mitt Romney took office in January 2003, so this problem was ignored by two administrations from both parties. It's not a partisan issue.

It's not helpful to blabber when you don't know what you're talking about.

Exellent article.

BVigby! Bigby! Bigby has to go. Let some heads roll for this debacle.